Nectar over allergies
We are Nectar and we are on a mission to put an end to allergies.
The time is now
120 million Americans suffer from allergies and their associated diseases. It is the #1 chronic condition impacting Americans today and a leading cause of lost productivity for employers around the country.
Nectar’s comprehensive care is here to change that.
AMERICANS SUFFERING FROM ALLERGIES
A passion for healthcare, for over a decade
Meet Kenneth Chahine, Ph.D., J.D., Founding CEO
Ken is a serial consumer healthcare entrepreneur with a passion for unlocking opportunities in underserved markets facing massive and inefficient consumer pain points. His superpower is his ability to combine his science, law and consumer experiences to develop strategies that deliver an exceptional service to the masses without compromising on the science.
Before founding Nectar, Ken was the EVP and founding executive of AncestryDNA and Ancestry Health, a consumer genealogy and disease risk predisposition testing company. While at AncestryDNA he took DNA testing mainstream and grew the total addressable market from a niche $10M to well over $2B by reinventing the end-to-end consumer experience. During his tenure, he grew the DNA business to over $500M in direct sales, while driving 20% cross sell into the Ancestry subscription business, led the team through hyper-growth, and scaled global operations to over 10M genomic tests annually.
Ken has demonstrated a talent for identifying winning products. Earlier in his career, Ken was the CEO of Helio Health, a company focused on early cancer detection from a simple blood spot, currently in late-stage FDA trials. He was also the CEO of Avigen, a gene therapy company focused on developing cures for monogenic disease. Avigen’s cure for hemophilia and treatment for Parkinson’s Disease were both recently approved in the EU and are on track for approval in the U.S.
Our team of industry professionals
We are a group of seasoned executives that have come together with a common purpose - putting an end to allergies. We champion science for good. And we’re here to change the world for good.
Chief Brand and Growth Officer
Chief Technology Officer
Chief Product Officer
Shyam Joshi, MD
Chief Medical & Scientific Officer
Co-founder & COO
Co-Founder & Head of New Business
Our medical board
Our medical board of scientists and clinicians advises and oversees every aspect of our products, to ensure the highest efficacy standards and best treatment that science has to offer.
Shyam Joshi, MD
Section Chief, Allergy and Immunology Oregon Health & Science University
Mohamed Shamji, PhD
Faculty of Medicine, National Heart & Lung Institute, Imperial College London
Michael S. Blaiss, MD, FACAAI, FAAAAI
Clinical Professor, Medical College of Georgia at Augusta University
John Zwetchkenbaum, MD
Chief Allergist and Founder of AAPRI, Warwick, RI
Our business advisory board
Advised by industry leaders in consumer products, health services, and patient advocacy, we are primed to bridge the best business practices with the highest quality healthcare.
Co-Founder and Chief Development Officer at Tend, Former VP of Real Estate and Development at One Medical
Tom X Lee
Chairman, Founder, Former CEO of One Medical Group
Founder of Method products, Olly, and Welly Health
Chair of the Board of the Directors, Food Allergy Research & Education (FARE) - Largest private funder of food allergy research